4//SEC Filing
Rangwala Reshma 4
Accession 0000950170-25-058137
CIK 0001503802other
Filed
Apr 23, 8:00 PM ET
Accepted
Apr 24, 4:40 PM ET
Size
4.9 KB
Accession
0000950170-25-058137
Insider Transaction Report
Form 4
Rangwala Reshma
EVP & Chief Medical Officer
Transactions
- Sale
Common Stock
2025-04-23$6.17/sh−419$2,585→ 28,853 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on April 4, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001825322
Filing Metadata
- Form type
- 4
- Filed
- Apr 23, 8:00 PM ET
- Accepted
- Apr 24, 4:40 PM ET
- Size
- 4.9 KB